NCT01222689 2020-07-31Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerNational Cancer Institute (NCI)Phase 2 Completed46 enrolled 13 charts
NCT00372944 2014-08-13AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine TherapyAstraZenecaPhase 2 Completed70 enrolled